Summary.-Separate and combined effects of bleomycin and X-rays on rates of uptake of [14C]thymidine into Ehrlich ascites cells were assessed for extracellular drug concentrations of 12 ,um (20,ug/ml) and radiation doses of 2*5 krad. Rates of DNA synthesis were followed by monitoring the activity of the acid-insoluble portion of the asynchronous culture. The 14C activity of the acid-soluble pool was assessed in determining the rate of passage of 14C-TdR across the cell membrane.
BLEOMYCINS are a group of basic glycopeptides produced by a strain of Streptomyces verticillus (Umezawa et al., 1966) . Commercially available Bleomycin (Lundbeck) is composed basically of bleomycins A2 and B2, and exhibits antibacterial and antineoplastic activity in vitro and in vivo (Umezawa et al., 1966; Ishizuka et al., 1967) . Bleomycin shows specific affinity for squamous cells Ichikawa et al., 1970) , making the compound especially useful in the treatment of human squamous carcinomas, which are generally unresponsive to most antineoplastic drugs (Grey and Michaels, 1972; Halnan et al., 1972) .
Bleomycin is known to inhibit DNA synthesis (Kunimoto, Hori and Umezawa, 1967; Suzuki et al., 1968) , cause DNAstrand scission (Fujiwara and Kondo, 1973; Terasima, Yasukawa and Umezawa, 1970) in vitro and in vivo, and to degrade single-and double-stranded DNA in vitro. This latter property has also been observed using synthetic deoxyribopolymers (Suzuki, Nagai and Yamaki, 1969; Haidle, 1971) . Degradation involves release of free bases, damage to the deoxyribose moiety and rupture of phosphodiester bonds, resulting in fragmentation of DNA Kuo and Haidle, 1973) .
The similarity of action of bleomycin and ionizing radiation, both at a molecular level involving DNA, and at a cellular level, as observed both by the sensitivity of cells in mitosis to bleomycin and by induced mitotic delay (Haidle and Bearden, 1975) , has aroused considerable interest in possible applications of the antibiotic in conjunction with radiation in tumour therapy.
Several reports have appeared in the literature involving combined schedules of radiation and bleomycin on cell survival in vitro and on tumour growth in vivo. Bleehen, Gillies and Twentyman (1974) of 20-40 ,ug bleomycin/ml media (12-24 ltM).
Irra4iation of the samples was carried out using a Marconi deep-therapy X-ray machine calibrated at 250 kV and 15 mA without filter, using a Baldwin-Farmer dosimeter.
The dose rate to the centre of the 10-ml 6 suspension, placed 5 cm from the tube face, was 2-5 krad/min. The cells were irradiated in air at room temperature. The irradiated suspension were subsequently incubated in a shaking water bath at 370C.
In the bleomycin experiments a contact of 30 min with the cell suspension 4t 37°C
was required for bleomycin effect to reach maximum for a particular concentration before the addition of the tracer.
In the combined treatment the suspensions were treated with the drug, irradiated and incubated at 370C as shown in Table II Results from concurrent studies (Kwok and Chapman, 1977) indicate that phosphorylation of the nucleoside TdR is a rapid process in relation to transport time, and that approximately 80% of the activity of the intracellular pool is made up of phosphorylated TdR, mostly TDP and TTP, whilst the remaining 20% is TdR and some thymine.
The results shown in Fig. 1 has an additive or less than additive effect on the activity of the acid-insoluble fraction from the lysed cells. However, a drug dose of 10 ptg/ml given 30 min before exposure to 2 5 krad X-rays together with a further 10 ,ug/ml immediately after radiation leads to a significantly greater than additive effect.
A series of experiments followed (Fig. 3 ) where the split drug dose technique was used for various single radiation doses in the range 1 2-7-5 krad. The results are compared with those calculated for a strictly additive effect, and suggest synergistic action for each radiation dose studied. The degree of synergism is about the same at all radiation doses studied, being 10-20% above the expected additive value.
DISCUSSION
The observed decrease in 14C activity of the acid-soluble intracellular pool (Figs 1, 2) , compared to controls, in EAT cells exposed to X-rays and subsequently The latter case can be dismissed, as results show (Table II) that the 14C activity of the acid-insoluble fraction decreases following exposure of the cells to radiation. The other two possibilities have been considered (Kwok and Chapman, 1977) and it has been shown that thymidine catabolism tends to decrease in cells exposed to X-rays. The decreased 14C activity of the intracellular pool is observed as a result of reduction in TdR influx rates, principally radiation-induced inhibition of facilitated diffusion.
Bleomycin, in contrast to ionizing radiation, appears to increase the size of the intracellular 14C pool. This effect may result from depression of DNA synthesis rates, but is more likely to involve an increase in the diffusion characteristics of TdR entering the cell.
The experiments involving bleomycin or radiation alone may be interpreted to mean that, whilst these agents appear to have opposing effects on the diffusion characteristics of TdR entering the cell, they both inhibit DNA synthesis as observed by the decreased incorporation of 14C into the acid-insoluble fraction (Table II) Synergistic action of bleomycin and radiation could arise from the prevention of repair of radiation-induced lesions by the action of bleomycin (Miyaki and Ono, 1971; Punnonen, Rantanen and Gronroos, 1974) . However, experiments involving bleomycin added simultaneously or shortly after exposure to X-rays (Table II) do not suggest any synergistic action. Similarly, synergism may arise through weakening of DNA strands by bleomycin binding, leading to more breaks per unit volume induced by X-rays than would be observed in cells exposed to X-rays alone. The effect is not observed for the single dose of bleomycin added before exposure (Table II) .
A possible explanation of the effectiveness of the split drug dose plus radiation treatment illustrated in Fig. 3 may include the concept of the relatively short biological half-life of bleomycin in EAT cells, together with the low permeability of cell plasma membranes to bleomycin. Results from concurrent studies (Chapman and Alalawi, 1977) show that the biological half-life of bleomycin in EAT cells is approximately 1 h, and that intracellular bleomycin at the steady state may represent less than 1°of the extracellular activity.
A hypothesis has been evolved proposing that the intracellular fraction of the drug added to the cell suspension before radiation in the split-dose experiments binds to DNA, weakening strands, resulting in radiation-induced free radical damage not observed with radiation alone.
However, bleomycin from this first dose is either physically unavailable within the cell, perhaps bound to protein (Chapman and Alalawi, 1976) or has been catabolized so that it cannot subsequently influence radiation-induced damage. A second dose of pharmacologically active 82 Ina I drug is required immediately after radiation to "fix" drug-sensitized, radiationinduced damage. The ability of bleomycin to inhibit the action of the enzyme ligase (Miyaki and Ono, 1971) , polymerases and ATP synthesis (Punnonen et at., 1974) may be involved in the apparent effect of bleomycin mentioned earlier.
The net result may be more DNA damage than is observed in either the irradiated or the drug-treated controls, leading to a further decrease in replication rates. This decrease in replication is observed as a synergistic action of bleomycin and X-rays in reducing the rate of [1 4C]TdR incorporation from the intracellular pool into DNA following phosphorylation of the nucleoside.
